🇺🇸 FDA
Patent

US 8163893

Pseudotyped retroviral vectors and methods of use thereof

granted A61KA61K48/00

Quick answer

US patent 8163893 (Pseudotyped retroviral vectors and methods of use thereof) held by The Regents of the University of California expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K48/00